Business
PDS Biotech Leadership to Present at 2025 CAGLA NeauxCancer Conference
Updated time slot of 11:00 AM CT on Friday, March 28, 2025PRINCETON, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech, will present at the 2025 Cancer Advocacy Group of Louisiana (CAGLA) NeauxCancer Conference in New Orleans
About this update from Pds Biotechnology Corporation
[{"type":"image","alt":"PDS Biotechnology Corporation","displaySize":"","headline":null,"caption":"PDS Biotechnology Corporation","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":42,"url":"https://media.zenfs.com/en/globenewswire.com/63fe962c3957c7a225a7c312a7c6913d"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6tw_s0aaD8Jse33jriazAg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTU5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/63fe962c3957c7a225a7c312a7c6913d","width":300,"height":42}},"lazy":false},{"type":"text","content":"Updated time slot of 11:00 AM CT on Friday, March 28, 2025","length":58,"tagName":"p"},{"type":"text","content":"PRINCETON, N.J., March 25, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that Frank Bedu-Addo, PhD, President and Chief Executive Officer of PDS Biotech, will present at the 2025 Cancer Advocacy Group of Louisiana (CAGLA) NeauxCancer Conference in New Orleans on Friday, March 28 – Saturday, March 29, 2025.","length":489,"tagName":"p"},{"type":"text","content":"Updated details of the presentation are as follows:","length":51,"tagName":"p"},{"type":"text","content":"2025 CAGLA NeauxCancer ConferenceDate: Friday, March 28, 2025Event: Scientific PresentationSession: Innovation TrackTime: 11:00 AM CT (formerly 4 PM CT)Location: The Roosevelt, New OrleansRegistration: To livestream the event, click here. For virtual registration, click the link below then select “Investor” in the “Registration Type” dropdown menu: https://web.cvent.com/event/d39429d9-aa77-42d9-9527-e1933ab84f19/regProcessStep1","length":437,"tagName":"p"},{"type":"text","content":"About PDS BiotechnologyPDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The Company has initiated a pivotal clinical trial to advance its lead program in advanced HPV16-positive head and neck squamous cell cancers. PDS Biotech’s lead investigational targeted immunotherapy Versamune® HPV is being developed in combination with a standard-of-care immune checkpoint inhibitor, and also in a triple combination including PDS01ADC, an IL-12 fused antibody drug conjugate (ADC), and a standard-of...